2025 UPDATES : Mangyaring dalhin ang lahat ng bagong insurance card sa iyong susunod na appointment at i-verify ang iyong address at numero ng telepono kapag nag-check in ka sa front desk. 

Klinikal na Pananaliksik at Pagsubok

uso 23272

Breast Cancer-Minimal/Molecular Residual Disease Detection at Therapy Monitoring sa mga Pasyenteng may Maagang Stage TNBC-Phase I (B-STRONGER-I) (01-PS-001)

 

Mga Uri ng Sakit: Pananaliksik sa Kanser sa Suso

Mga Kinakailangan sa Kwalipikasyon:

• Histologically documented TNBC (ER ≤10% by IHC, PR ≤10% by IHC and HER2 0 or
1+ by IHC or FISH ratio <2 or HER2 gene copy number of <6)
• Early-stage (stage I-III) TNBC scheduled to undergo NAC treatment with curative
intent
• Be willing to provide blood samples before and during treatment
• Have available biopsy tissue
• Pts with current or history of another primary cancer within 5 years of study entry are
excluded
• Pt that started systemic therapy for BC are excluded
• No blood transfusion within two weeks before collection of blood for central ctDNA
testing

Available sa: